Search
Close this search box.
News

Latest Industry Updates

From company milestones to industry breakthroughs, uncover the stories making waves and shaping the narrative in real time.

CluePoints Experiences Continued Rapid Growth As Demand For RBx Rises
WAYNE, PA – April 09, 2019: CluePoints, a leading provider of Risk-Based Study Execution(RBx) and Data...
Read
FDA Offers Further RBM Guidance Stressing Data Quality Oversight
Since finalizing its risk-based monitoring guidance in 2013, the FDA is providing additional information...
Read
New! Registration Open For CluePoints’ RBM Roadshows – Pick From San Francisco Or La Jolla!
We’re delighted to announce that registration for CluePoints’ US Risk-Based Quality Management Roadshow is...
Read
How SMEs Can Achieve Regulatory Compliance Through a Risk-Based Approach
Since the introduction of the ICH E6 (R2) addendum, the industry has seen a rise in the implementation...
Read
Update on ICH E6 (R2) Guideline for GCP
The ICH E6 R2 Addendum is starting to have a significant, positive impact on clinical trial design –...
Read
A Revolutionary Cure for RBM and Centralized Monitoring
In the clinical trials industry there is a tendency to watch and wait, which has been the case with...
Read
1 19 20 21 22 23 29
None found. Please check back later!
None found. Please check back later!